Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
28,737
-3,829
-12% -$207K 0.12% 146
2025
Q4
$1.6M Buy
32,566
+3,527
+12% +$165K 0.12% 138
2025
Q3
$1.25M Buy
+29,039
New +$1.13M 0.16% 112
2024
Q3
Sell
-8,413
Closed -$323K 353
2024
Q2
$323K Sell
8,413
-15,729
-65% -$662K 0.03% 261
2024
Q1
$1.03M Buy
24,142
+1,127
+5% +$46.5K 0.11% 149
2023
Q4
$885K Buy
+23,015
New +$826K 0.09% 148

Other funds holding GSK

Leo Wealth LLC's GSK Position: Q1 2026 in Review

Leo Wealth LLC reduced its GSK (GSK) stake by 12% in Q1 2026, selling an estimated $207K and leaving 28,737 shares worth $1.59M. The position accounts for 0.12% of the portfolio, ranked #146.

Leo Wealth LLC first reported a position in GSK in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.6M in Q4 2025. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Leo Wealth LLC held 28,737 shares of GSK worth $1.59M as of Q1 2026.
  • Leo Wealth LLC sold 3,829 GSK shares in Q1 2026, an estimated $207K.
  • GSK made up 0.12% of Leo Wealth LLC's portfolio in Q1 2026, its #146 holding.
  • Leo Wealth LLC first reported a position in GSK in Q4 2023 and has held it in 6 quarters since.
  • Leo Wealth LLC's GSK position peaked at $1.6M in Q4 2025.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.